Profilo
Mr. Donald R.
Sellers is President & Chief Executive Officer at CardioPharma, Inc. and Founding Member at Life Science Angels, Inc.
Mr. Sellers was previously employed as President, Chief Executive Officer & Director by SciClone Pharmaceuticals, Inc., an Advisor by WI Harper Group, Inc., Country Manager by Pfizer Inc., a Director-Worldwide Exports by Revlon Healthcare, an Officer by Military Intelligence Academy, Regional President by Sterling Drug, Inc., and Vice President by The Pritzker Organization LLC.
He received his undergraduate degree from Lafayette College, a graduate degree from the Thunderbird School of Global Management, and an MBA from the Thunderbird School of Global Management.
Posizioni attive di Donald R. Sellers
| Società | Posizione | Inizio |
|---|---|---|
Life Science Angels, Inc.
Life Science Angels, Inc. Miscellaneous Commercial ServicesCommercial Services Provides investment services | Corporate Officer/Principal | - |
Precedenti posizioni note di Donald R. Sellers
| Società | Posizione | Fine |
|---|---|---|
WI Harper Group, Inc.
WI Harper Group, Inc. Investment ManagersFinance WI Harper invests in companies located in the Unites States, Greater China and Asia Pacific. The firm focuses on a broad range of sectors and industries. It participates in early and growth stage capital transactions. | Corporate Officer/Principal | 31/12/2007 |
| SCICLONE PHARMACEUTICALS, INC. | Amministratore Delegato | 14/07/2004 |
Revlon Healthcare | Corporate Officer/Principal | - |
Military Intelligence Academy
Military Intelligence Academy Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Pritzker Organization LLC
The Pritzker Organization LLC Investment ManagersFinance The Pritzker Organization invests in companies located in the United States with an enterprise value of USD 100 - 1000 billion and an EBITDA of USD 10 - 150 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for growth stage capital requirements with an investment size of USD 75 -300 million for majority deals & USD 15 - 100 million for minority and structured deals. The firm also acquires majority and minority interest. | Corporate Officer/Principal | - |
Formazione di Donald R. Sellers
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
SciClone Pharmaceuticals LLC
SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer and infectious diseases | Health Technology |
Thunderbird School of Global Management
Thunderbird School of Global Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sterling Drug, Inc.
Sterling Drug, Inc. Household/Personal CareConsumer Non-Durables Markets pharmaceutical specialties & personal products | Consumer Non-Durables |
Lafayette College
Lafayette College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WI Harper Group, Inc.
WI Harper Group, Inc. Investment ManagersFinance WI Harper invests in companies located in the Unites States, Greater China and Asia Pacific. The firm focuses on a broad range of sectors and industries. It participates in early and growth stage capital transactions. | Finance |
The Pritzker Organization LLC
The Pritzker Organization LLC Investment ManagersFinance The Pritzker Organization invests in companies located in the United States with an enterprise value of USD 100 - 1000 billion and an EBITDA of USD 10 - 150 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for growth stage capital requirements with an investment size of USD 75 -300 million for majority deals & USD 15 - 100 million for minority and structured deals. The firm also acquires majority and minority interest. | Finance |
CardioPharma, Inc.
CardioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and combinatorial cardiovascular products | Health Technology |
Revlon Healthcare | |
Military Intelligence Academy
Military Intelligence Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Life Science Angels, Inc.
Life Science Angels, Inc. Miscellaneous Commercial ServicesCommercial Services Provides investment services | Commercial Services |
















